Cymbalta 30 mg hard gastro-resistant capsules, Vimpat 50 mg film-coated tablets
Approved small_molecule active
Quick answer
Cymbalta 30 mg hard gastro-resistant capsules, Vimpat 50 mg film-coated tablets for chemotherapy-induced neuropathic pain is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- chemotherapy-induced neuropathic pain
- Phase
- Approved
- Modality
- small_molecule
- Status
- active